Ryan T. Backer - Concepedia

Author

Ryan T. Backer

Eli Lilly (United States)

Also Known As

Ryan Backer, Ryan T. Backer

Publications

280

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

Ryan T. Backer is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	158
2	Natural Sciences	3	3	95
3	Chemical Biology	3	3	95
4	Biochemistry	2	2	82
5	Molecular Biology	2	2	23

Ryan T. Backer

Publications

274

Citations

H-Index

Page 1

	Year	Citations
Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics J.G. Luz, Stephen Antonysamy, Steven L. Kuklish, Journal of Medicinal Chemistry	2015	65
Synthesis and Structure−Activity Relationships of Novel Arylpiperazines as Potent and Selective Agonists of the Melanocortin Subtype-4 Receptor Timothy I. Richardson, Paul L. Ornstein, Karin Briner, Journal of Medicinal Chemistry Drug TargetNovel ArylpiperazinesPharmacotherapySulfonamide 39Chemical Biology	2004	61
Ageism Interventions: The Need for An Ecological Perspective Tracey Gendron, Alexa Van Aartrjik, Kyrié Carpenter, Journal of Aging & Social Policy	2022	51
3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity Matthew J. Fisher, Ryan T. Backer, Vanessa Barth, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyPotent Mglur1MedicinePharmacological AgentNeuropharmacology	2012	29
Privileged structure-based ligands for melanocortin receptors—tetrahydroquinolines, indoles, and aminotetralines Matthew J. Fisher, Ryan T. Backer, Saba Husain, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicineReceptor (Biochemistry)Structure-based LigandsPharmacology	2005	24
Synthesis and structure–activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor Qing Shi, Paul L. Ornstein, Karin Briner, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryFunctional SelectivityMedicineNatural Sciences	2005	21
Privileged structure based ligands for melanocortin receptors—Substituted benzylic piperazine derivatives Matthew J. Fisher, Ryan T. Backer, Iván Collado, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyDerivativesPrivileged StructureFunctional SelectivityNatural Sciences	2005	13
Privileged structure based ligands for melanocortin receptors—4,4-Disubstituted piperidine derivatives Steven L. Kuklish, Ryan T. Backer, Karin Briner, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyPrivileged StructureMedicineReceptor (Biochemistry)Molecular Biology	2006	10

Page 1